HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
776
CareCloud
CCLD
$152M
|
KD
Kevin Dede
| $3.59 | $5 |
39%
upside
| Buy |
3 Mar ‘23
2 years ago |
|
777
LAVA Therapeutics
LVTX
$41.3M
|
SR
Swayampakula Ramakanth
| $1.57 | $9 |
473%
upside
| Buy |
17 Feb ‘23
2 years ago |
|
778
MEI Pharma
MEIP
$97.5M
|
AF
Andrew Fein
| $2.97 | $40 |
1,247%
upside
| Buy |
13 Feb ‘23
2 years ago |
|
779
LiveOne
LVO
$59.3M
|
KD
Kevin Dede
| $0.5134 | $3 |
484%
upside
| Buy |
10 Feb ‘23
2 years ago |
|
780
Matinas BioPharma
MTNB
$9.16M
|
AF
Andrew Fein
| $1.65 | $150 |
8,991%
upside
| Buy |
31 Jan ‘23
2 years ago |
|
781
Celularity
CELU
$60.6M
|
SR
Swayampakula Ramakanth
| $2.27 | $25 |
1,001%
upside
| Buy |
30 Jan ‘23
2 years ago |
|
782
Fate Therapeutics
FATE
$116M
|
RB
Robert Burns
| $1.01 | $7 |
593%
upside
| Neutral |
24 Jan ‘23
2 years ago |
|
|
HIVE
783
HIVE Digital Technologies
HIVE
$707M
|
KD
Kevin Dede
| $3.08 | $5 |
62%
upside
| Buy |
12 Dec ‘22
2 years ago |
|
|
ADAG
784
Adagene
ADAG
$111M
|
SR
Swayampakula Ramakanth
| $2.35 | $5 |
113%
upside
| Buy |
7 Dec ‘22
2 years ago |
|
785
Allogene Therapeutics
ALLO
$253M
|
DC
Debjit Chattopadhyay
| $1.14 | $29 |
2,444%
upside
| Buy |
21 Nov ‘22
2 years ago |
|
786
Dominari Holdings
DOMH
$104M
|
VB
Vernon Bernardino
| $6.72 | $16 |
138%
upside
| Buy |
11 Nov ‘22
2 years ago |
|
787
Cellectar Biosciences
CLRB
$16.6M
|
SR
Swayampakula Ramakanth
| $5.21 | $120 |
2,203%
upside
| Buy |
4 Nov ‘22
2 years ago |
|
788
Aptorum Group
APM
$12.8M
|
VB
Vernon Bernardino
| $1.79 | $80 |
4,369%
upside
| Buy |
7 Oct ‘22
2 years ago |
|
789
Benitec Biopharma
BNTC
$366M
|
PT
Patrick Trucchio
| $13.95 | $68 |
387%
upside
| Buy |
23 Sep ‘22
3 years ago |
|
790
AnaptysBio
ANAB
$630M
|
GS
Gobind Singh
| $22.53 | $35 |
55%
upside
| Buy |
19 Sep ‘22
3 years ago |
|
791
Immunic
IMUX
$87.4M
|
GS
Gobind Singh
| $0.8862 | $26 |
2,834%
upside
| Buy |
19 Sep ‘22
3 years ago |
|
792
AgriFORCE Growing Systems
AGRI
$2.97M
|
AD
Amit Dayal
| $2.27 | $247,500 |
10,902,984%
upside
| Buy |
31 Aug ‘22
3 years ago |
|
793
CervoMed
CRVO
$89.4M
|
SR
Swayampakula Ramakanth
| $10.27 | $14.25 |
39%
upside
| Buy |
16 Aug ‘22
3 years ago |
|
794
CASI Pharmaceuticals
CASI
$36.7M
|
SR
Swayampakula Ramakanth
| $2.37 | $12 |
406%
upside
| Buy |
15 Aug ‘22
3 years ago |
|
795
BioAtla
BCAB
$40M
|
SR
Swayampakula Ramakanth
| $0.6808 | $20 |
2,838%
upside
| Buy |
10 Aug ‘22
3 years ago |
|
796
Celldex Therapeutics
CLDX
$1.65B
|
JH
Joseph Hafling
| $24.82 | $73 |
194%
upside
| Buy |
1 Jul ‘22
3 years ago |
|
|
RNTX
797
Rein Therapeutics, Inc. Common Stock
RNTX
$29.6M
|
EW
Edward White
| $1.27 | $20 |
1,475%
upside
| Buy |
30 Jun ‘22
3 years ago |
|
798
Tyra Biosciences
TYRA
$657M
|
RS
Raghuram Selvaraju
| $12.32 | $12 |
3%
downside
| Buy |
23 Jun ‘22
3 years ago |
|
799
TherapeuticsMD
TXMD
$12.6M
|
DT
Douglas Tsao
| $1.09 | $10 |
817%
upside
| Neutral |
7 Jun ‘22
3 years ago |
|
800
Frontline
FRO
$5.06B
|
MF
Magnus Fyhr
| $22.75 | $10 |
56%
downside
| Neutral |
25 May ‘22
3 years ago |
|